No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
OMGA Omega Therapeutics
- 1.980
- -0.130-6.16%
Close May 29 16:00 ET
- 2.080
- +0.100+5.05%
Post 18:26 ET
109.21MMarket Cap-1192P/E (TTM)
2.110High1.970Low434.34KVolume2.080Open2.110Pre Close879.19KTurnover2.03%Turnover RatioLossP/E (Static)55.15MShares8.88052wk High2.64P/B42.30MFloat Cap1.30052wk Low--Dividend TTM21.36MShs Float31.410Historical High--Div YieldTTM6.64%Amplitude1.300Historical Low2.024Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Omega Therapeutics Appoints Kaan Certel, Ph.d., as Chief Business Officer
Stocks With More Than 10% Short Interest - Finviz Screener
12 Health Care Stocks Moving In Monday's Intraday Session
GainersCareCloud (NASDAQ:CCLD) stock moved upwards by 80.5% to $2.27 during Monday's regular session. The company's market cap stands at $36.6 million. Novavax (NASDAQ:NVAX) stock rose 42.17% to $12.6
Express News | HC Wainwright & Co. Reiterates Buy on Omega Therapeutics, Maintains $12 Price Target
Buy Rating Reaffirmed for Omega Therapeutics on Strong Clinical and Financial Performance
Novo Nordisk, Flagship to Develop Next-generation Obesity Drugs
Comments
$Omega Therapeutics(OMGA.US$
NEWS
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
NEWS
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
1
$Omega Therapeutics(OMGA.US$ let’s go!
2
RECAP
Investors Rethink Rate Cut Bets
US equities ended Friday slightly higher, but gains weren't enough to keep major indices in the green in the first trading week of the year. The stock market ended their nine-week winning streak as investors rethink bets of aggressive interest rate cuts this year amid signs of continued strength in the labor market.
The $S&P 500 Index(.SPX.US$ rose 0.2% to close at 4,697.24 Friday, while the $Nasdaq Composite Index(.IXIC.US$ rose less...
Investors Rethink Rate Cut Bets
US equities ended Friday slightly higher, but gains weren't enough to keep major indices in the green in the first trading week of the year. The stock market ended their nine-week winning streak as investors rethink bets of aggressive interest rate cuts this year amid signs of continued strength in the labor market.
The $S&P 500 Index(.SPX.US$ rose 0.2% to close at 4,697.24 Friday, while the $Nasdaq Composite Index(.IXIC.US$ rose less...
37
2
$Omega Therapeutics(OMGA.US$ tumbled 18%, giving back some of its meteoric gains on Thursday that were driven by optimism over the clinical-stage biotechnology company's research collaboration pact with Novo Nordisk.
Omega shares almost doubled Thursday after the company said its flagship’s Pioneering Medicines initiative, and Novo Nordisk will jointly advance an obesity management program through preclinical development and...
Omega shares almost doubled Thursday after the company said its flagship’s Pioneering Medicines initiative, and Novo Nordisk will jointly advance an obesity management program through preclinical development and...
7
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg